Regina E Groves Atri Cure, Inc. (ATRC) insider trading activity

Regina E Groves is Director of AtriCure, Inc.. Currently has a direct ownership of 36,167 shares of ATRC, which is worth approximately $1.06 Million. The most recent transaction as insider was on May 19, 2025, when has been sold 5,401 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.2K

17.56% 3M change

17.56% 12M change

Total Value Held $1.06 Million

REGINA E GROVES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2025	BUY Grant, award, or other acquisition	-	5,401 Added 12.99%	36,167 Common Stock
May 13 2024	BUY Grant, award, or other acquisition	-	7,788 Added 20.2%	30,766 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	3,186 Added 12.18%	22,978 Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	3,564 Added 15.26%	19,792 Common Stock
Sep 15 2021	SELL Open market or private sale	$235,848 $74.73 p/Share	3,156 Reduced 16.31%	16,194 Common Stock
May 26 2021	SELL Open market or private sale	$302,766 $71.95 p/Share	4,208 Reduced 17.86%	19,350 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	1,749 Added 6.91%	23,558 Common Stock
Apr 30 2021	BUY Open market or private purchase	$2,607 $76.68 p/Share	34 Added 0.21%	16,228 Common Stock

Also insider at

FLGT

Fulgent Genetics, Inc. Healthcare

REG

Regina E Groves

Director

Mason, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Value

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

Operation

Value

Type

News

Receive news related to AtriCure, Inc.

Track Activities on ATRC

Account